AllianceBernstein
COGT icon

AllianceBernstein’s Cogent Biosciences COGT Stock Holding History

AllianceBernstein’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Buy
572,694
+415,384
+264% +$14.5M 0.01% 878
2026
Q1 		$5.59M Buy
157,310
+1,800
+1% +$66.5K ﹤0.01% 1485
2025
Q4 		$5.52M Buy
155,510
+30,890
+25% +$868K ﹤0.01% 1491
2025
Q3 		$1.79M Buy
124,620
+42,560
+52% +$504K ﹤0.01% 2066
2025
Q2 		$589K Sell
82,060
-151,763
-65% -$841K ﹤0.01% 2544
2025
Q1 		$1.4M Sell
233,823
-231,119
-50% -$1.81M ﹤0.01% 2072
2024
Q4 		$3.63M Buy
464,942
+382,882
+467% +$3.82M ﹤0.01% 1644
2024
Q3 		$886K Buy
82,060
+9,860
+14% +$96K ﹤0.01% 2383
2024
Q2 		$609K Hold
72,200
– – ﹤0.01% 2563
2024
Q1 		$485K Hold
72,200
– – ﹤0.01% 2594
2023
Q4 		$425K Hold
72,200
– – ﹤0.01% 2689
2023
Q3 		$704K Hold
72,200
– – ﹤0.01% 2397
2023
Q2 		$855K Hold
72,200
– – ﹤0.01% 2355
2023
Q1 		$779K Hold
72,200
– – ﹤0.01% 2344
2022
Q4 		$835K Buy
72,200
+16,700
+30% +$207K ﹤0.01% 2372
2022
Q3 		$828K Buy
55,500
+15,800
+40% +$217K ﹤0.01% 2397
2022
Q2 		$358K Buy
+39,700
New +$271K ﹤0.01% 2820
2019
Q2 		– Sell
-2,900
Closed -$51K – 3153
2019
Q1 		$51K Sell
2,900
-450
-13% -$7.69K ﹤0.01% 3082
2018
Q4 		$59K Hold
3,350
– – ﹤0.01% 3045
2018
Q3 		$138K Buy
3,350
+725
+28% +$40.9K ﹤0.01% 3043
2018
Q2 		$151K Buy
+2,625
New +$126K ﹤0.01% 3015

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein's COGT Position: Q2 2026 in Review

AllianceBernstein increased its Cogent Biosciences (COGT) stake by 264% in Q2 2026, buying an estimated $14.5M and bringing the position to 572,694 shares worth $22M. The position accounts for 0.01% of the portfolio, ranked #878.

AllianceBernstein first reported a position in COGT in Q2 2018 and has held it in 21 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • AllianceBernstein held 572,694 shares of Cogent Biosciences worth $22M as of Q2 2026.
  • AllianceBernstein bought 415,384 Cogent Biosciences shares in Q2 2026, an estimated $14.5M.
  • Cogent Biosciences made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #878 holding.
  • AllianceBernstein first reported a position in Cogent Biosciences in Q2 2018 and has held it in 21 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.